Melanoma Cancer Market: Global Market Size and Forecast 2018-2023

Posted by pranshu@95 on August 29th, 2019

Orion Market Research (OMR) recently published a market research report on the global Melanoma Cancer Market. According to OMR analysis, the global melanoma cancer market is estimated to grow at a significant CAGR during the forecast period (2018-2023). Melanoma is a skin cancer that develops due to the exposure of the UV rays on the skin. The disease is curable when detected and treated in the early stages, and hence have a high success rate. Increasing incidence of melanoma across the globe and rising ozone layer depletion due to global warming are the major factors that are driving the market during the forecast period. Additionally, overexposure to radiation during certain treatments or exposure to chemicals during treatment, increasing awareness about cancer, and rising healthcare expenditure is also motivating the market.

 A full report of global melanoma cancer market is available at: https://www.omrglobal.com/industry-reports/melanoma-cancer-market/

Furthermore, the global melanoma skin cancer market is segmented into by type, by diagnosis, and by therapy. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1. Global melanoma market, by cancer type

• Non-invasive melanoma
• Invasive melanoma

2. Global melanoma market, by diagnosis method

• Biopsy
• Computed tomography (cat) scan
• Magnetic resonance imaging (mri)
• Positron emission tomography (pet) scan

3. Global melanoma market, by therapy

• Surgery
• Immunotherapy
• Targeted therapy
• Chemotherapy
• Radiation therapy

Region Covered

• North America (the US and Canada)
• Europe (UK, Germany, France, Spain, Italy, and ROE)
• Asia-Pacific (China, India, Japan, and ROAP)
• Rest of the World

Company Profile

•  Ab Sciences
•  Abbvie Inc.
•  Aduro Biotech, Inc.
•  Amgen, Inc.
•  Astrazeneca
•  Bristol-Myers Squibb Company
•  Castle Biosciences, Inc.
•  Celgene Corporation
•  Daiichi Sankyo Company, Limited
•  Enb Therapeutics, LLC.
•  F. Hoffman-La Roche Ltd.
•  Incyte Corporation
•  Johnson & Johnson
•  Mela Sciences, Inc.
•  Merck & Co., Inc.
•  Novartis Ag
•  Pierre Fabre
•  Scibase Holding Ab
•  Teleskin Doo

The key objectives of the Melanoma Cancer Market study:

• To analyze the Melanoma Cancer Market by segments with historical data of 2017 and 2018 and forecast to 2025.
• To study the key factors influencing the growth of the market.
• Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.
• To analyze Melanoma Cancer Market growth, global trends, future prospectus and contribution to the market.

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667,+91 780-304-0404